Nitinotes Surgical

Nitinotes Surgical is a medical device startup based in Caesarea, Israel, established in 2014. The company has developed a pioneering solution called EndoZip™, an automated endoscopic suturing system designed to address obesity with minimally invasive methods. This innovative product has gained significant recognition in the medical field, supported by clinical success and endorsements from key opinion leaders (KOLs). The latest milestone for Nitinotes Surgical is the $10.10M Series B investment on 25 September 2023, which was secured from MTIP, a prominent investor in the industry. This funding is expected to further fuel the development and commercialization of EndoZip™, aiming to provide a safer and simpler suturing solution for endoscopic gastroplasty. With a focus on the Medical Devices sector, Nitinotes Surgical aims to make a substantial impact by offering a more accessible and effective alternative for the millions of patients dealing with obesity class I & II, for whom traditional bariatric surgery may not be a viable option.